Teladoc Inc Stock Research

Market Summary

USD25.22+0.22

Market Closed

0.88%

TDOC Alerts

3 major insider sales recently.
Big fall in earnings (Y/Y)
Losses in recent quarter

TDOC Stock Price

TDOC RSI Chart

TDOC Valuation

Market Cap

4.1B

Price/Earnings (Trailing)

-0.3

Price/Sales (Trailing)

1.71

EV/EBITDA

-0.24

Price/Free Cashflow

23.76

TDOC Price/Sales (Trailing)

TDOC Profitability

EBT Margin

-567.69%

Return on Equity

-591.9%

Return on Assets

-314.35%

Free Cashflow Yield

4.21%

TDOC Fundamentals

TDOC Revenue

Revenue (TTM)

2.4B

Revenue Y/Y

15.06%

Revenue Q/Q

4.3%

TDOC Earnings

Earnings (TTM)

-13.7B

Earnings Y/Y

-34.6K%

Earnings Q/Q

-5.1K%

Price Action

52 Week Range

21.6077.50

(Low)(High)

Last 7 days

-1.4%

Last 30 days

-16.9%

Last 90 days

-7.3%

Trailing 12 Months

-54.1%

TDOC Financial Health

Current Ratio

3.29

TDOC Investor Care

Shares Dilution (1Y)

1.48%

Diluted EPS (TTM)

-84.6

Peers (Alternatives to Teladoc)

View All Peers In Detail

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
HCA	70.6B	60.2B	-4.86%	-6.89%	12.5	1.17	2.52%	-18.88%
CERN	27.9B	-	0.98%	20.75%	47.36	4.81	-	-
VEEV	27.3B	2.1B	-0.47%	-1.83%	68.93	13.15	17.88%	-8.53%
LH	19.6B	14.9B	-11.65%	-18.57%	15.35	1.32	-7.72%	-46.20%
MID-CAP
CHNG	9.0B	3.5B	11.88%	31.28%	-116.8	2.57	7.15%	-34.72%
TDOC	4.1B	2.4B	-16.92%	-54.15%	-0.3	1.71	18.41%	-3085.58%
OMCL	2.5B	1.3B	1.97%	-58.05%	451.35	1.97	14.48%	-92.74%
SMALL-CAP
PHR	1.8B	262.3M	-10.85%	40.30%	-9.92	6.98	33.16%	-131.28%
MDRX	1.5B	837.2M	-24.90%	-38.38%	24.16	1.75	3.88%	-92.18%
NXGN	1.1B	625.9M	-11.35%	-14.10%	49.5	1.81	6.21%	3223.77%
SLP	864.4M	53.5M	4.26%	2.91%	80.77	16.17	10.94%	3.61%
HCAT	657.1M	276.2M	-14.12%	-43.94%	-4.78	2.38	14.18%	10.32%
OPRX	234.3M	63.1M	-26.73%	-64.73%	-22.34	3.71	9.93%	-1043.45%
TRHC	155.2M	357.1M	-7.94%	20.85%	-1.11	0.43	33.22%	-57.66%
WORX	4.6M	4.3M	-19.40%	-50.10%	-1.89	1.09	-12.25%	9.68%

Financials for Teladoc

Income Statement (Last 12 Months)
Description	(%) Q/Q	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4
Revenue	3.6%	2,406,840,000	2,323,366,000	2,233,622,000	2,144,382,000	2,032,707,000
S&GA Expenses	-1.3%	227,172,000	230,223,000	238,191,000	244,117,000	250,581,000
R&D Expenses	1.4%	333,629,000	328,920,000	321,355,000	321,288,000	311,884,000
EBITDA	-38.4%	-13,437,351,000	-9,709,548,000	-9,743,248,000	-6,795,388,000	-
EBITDA Margin	-33.6%	-5.58	-4.18	-4.36	-3.17	-
Earnings Before Taxes	-37.8%	-13,663,343,000	-9,912,157,000	-9,918,207,000	-6,946,181,000	-384,656,000
EBT Margin	-33.1%	-5.68	-4.27	-4.44	-3.24	-
Interest Expenses	36.9%	-30,035,000	-47,584,000	-63,720,000	-80,365,000	-
Net Income	-38.5%	-13,659,531,000	-9,860,445,000	-9,871,309,000	-6,903,667,000	-428,793,000
Net Income Margin	-33.7%	-5.68	-4.24	-4.42	-3.22	-
Free Cahsflow	-10.8%	172,812,000	193,743,000	209,937,000	169,937,000	-

* denotes actual numbers (not divided by Millions)
Balance Sheet					(In Millions)
Description	(%) Q/Q	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4
Assets	-46.4%	4,345	8,104	8,103	11,092	17,735
Current Assets	2.2%	1,315	1,288	1,257	1,208	1,225
Cash Equivalents	2.1%	918	900	881	836	893
Inventory	-5.1%	56.00	59.00	60.00	71.00	73.00
Net PPE	8.7%	30.00	27.00	27.00	28.00	27.00
Goodwill	-77.9%	1,073	4,846	4,858	7,900	14,504
Current Liabilities	-2.8%	400	411	371	307	331
LT Debt, Current	-	-	-	-	-	-
Shareholder's Equity	-61.9%	2,308	6,053	6,085	9,143	16,046
Retained Earnings	-34.0%	-15,008	-11,198	-11,124	-8,023	-1,421
Additional Paid-In Capital	0.3%	17,359	17,300	17,239	17,177	17,473
Shares Outstanding	0.4%	163	162	162	161	160

Cashflow (Last 12 Months)					(In Millions)
Description	(%) Q/Q	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4
Cashflow From Operations	-8.5%	189	207	221	180	194
Share Based Compensation	-4.7%	218	229	245	277	303
Cashflow From Investing	-25.2%	-167	-133	-127	-84.52	-72.98
Cashflow From Financing	-25.7%	6.00	9.00	9.00	22.00	41.00

Risks for TDOC

What is the probability of a big loss on TDOC?

96.2%

Probability that Teladoc stock will be more than 20% underwater in next one year

60.4%

Probability that Teladoc stock will be more than 30% underwater in next one year.

54.2%

Probability that Teladoc stock will be more than 40% underwater in next one year.

*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does TDOC drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Teladoc was unfortunately bought at previous high price.

Drawdowns

Returns for TDOC

Cumulative Returns on TDOC

11.6%

7-Year Cumulative Returns

-9.5%

5-Year Cumulative Returns

-42.0%

3-Year Cumulative Returns

What are the long-term rolling returns for TDOC?

FIve years rolling returns for Teladoc.

Annualized Returns

Which funds bought or sold TDOC recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
2023-03-10	BAILLIE GIFFORD & CO	reduced	-9.49	-20,689,500	112,272,000	0.12%
2023-03-10	VICTORY CAPITAL MANAGEMENT INC	reduced	-0.05	-30,453	416,547	-%
2023-03-06	Rockefeller Capital Management L.P.	reduced	-20.85	-52,000	144,000	-%
2023-03-02	OLIVER LAGORE VANVALIN INVESTMENT GROUP	unchanged	-	-1,640	24,360	0.01%
2023-02-28	Voya Investment Management LLC	reduced	-0.66	-47,439	594,561	-%
2023-02-24	BBJS FINANCIAL ADVISORS, LLC	new	-	591	591	-%
2023-02-24	SRS Capital Advisors, Inc.	reduced	-0.36	-1,040	12,960	-%
2023-02-24	National Pension Service	unchanged	-	-57.00	520	-%
2023-02-24	NATIXIS	reduced	-95.59	-15,871,700	680,316	-%
2023-02-22	TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY	sold off	-100	-756,000	-	-%

Latest Funds Activity

Are funds buying TDOC calls or puts?

Calls

Puts

Are funds bullish or bearish(Calls - Puts)?

Net Call Options

No. of funds that own TDOC

No. of Funds

Teladoc News

Schedule 13G FIlings of Teladoc

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 09, 2023	vanguard group inc	8.94%	14,476,155	SC 13G/A
Feb 07, 2023	blackrock inc.	6.2%	9,961,219	SC 13G/A
Feb 03, 2023	sumitomo mitsui trust holdings, inc.	5.01%	8,125,231	SC 13G/A
Jul 05, 2022	baillie gifford & co	4.80%	7,739,623	SC 13G/A
Mar 11, 2022	blackrock inc.	5.9%	9,485,340	SC 13G/A
Feb 14, 2022	nikko asset management americas, inc.	5.47%	8,755,058	SC 13G
Feb 09, 2022	ark investment management llc	11.82%	18,922,198	SC 13G/A
Feb 08, 2022	blackrock inc.	5.9%	9,485,340	SC 13G
Feb 04, 2022	sumitomo mitsui trust holdings, inc.	5.70%	9,140,808	SC 13G
Jan 26, 2022	baillie gifford & co	6.79%	10,877,063	SC 13G/A

TDOC Fair Value

Teladoc fair value in different scenarios

The table shows the Fair Value estimates for Teladoc for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.

Fair Value	Very Pessimistic	Pessimistic	Base Case	Optimistic	Very Optimistic
Very Low Inflation	2.78 -88.98%	6.06 -75.97%	16.14 -36.00%	34.85 38.18%	72.42 187.15%
Current Inflation	2.54 -89.93%	5.45 -78.39%	14.21 -43.66%	30.24 19.90%	62.23 146.75%
Very High Inflation	2.24 -91.12%	4.72 -81.28%	11.93 -52.70%	24.86 -1.43%	50.47 100.12%

Historical Teladoc Fair Value Estimates

Very Pessimistic Case

Pessimistic Case

Fair Value

Optimistic Case

Very Optimistic Case

Closing Stock Price

Recent SEC filings of Teladoc

View All Filings

Date Filed	Form Type	Document
Mar 07, 2023	4	Insider Trading
Mar 07, 2023	4	Insider Trading
Mar 07, 2023	4	Insider Trading
Mar 07, 2023	4	Insider Trading
Mar 07, 2023	4	Insider Trading
Mar 07, 2023	4	Insider Trading
Mar 07, 2023	4	Insider Trading
Mar 07, 2023	4	Insider Trading
Mar 07, 2023	4	Insider Trading
Mar 07, 2023	4	Insider Trading

Latest Insider Trading transactions for TDOC

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
2023-03-03	Vandervoort Adam C	sold	-132,042	25.911	-5,096	chief legal officer, secretary
2023-03-03	GOREVIC JASON N	sold	-571,078	25.911	-22,040	chief executive officer
2023-03-03	Verstraete Stephany	sold	-74,442	25.911	-2,873	chief marketing officer
2023-03-03	Murthy Mala	sold	-192,726	25.911	-7,438	chief financial officer
2023-03-03	Turitz Andrew	sold	-46,510	25.911	-1,795	svp - corporate development
2023-03-03	Trencher Daniel	sold	-47,624	25.911	-1,838	svp corporate strategy
2023-03-02	Murthy Mala	sold	-192,878	25.362	-7,605	chief financial officer
2023-03-02	Jensen Claus Torp	sold	-85,926	25.362	-3,388	chief innovation officer
2023-03-02	GOREVIC JASON N	acquired	-	-	44,814	chief executive officer
2023-03-02	Verstraete Stephany	acquired	-	-	8,102	chief marketing officer

About Teladoc

Jason N. Gorevic

www.teladoc.com

5100

Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform and program services. The company serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. It offers its products and services under the Teladoc, Livongo, and BetterHelp brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. The company was incorporated in 2002 and is headquartered in Purchase, New York.

TDOC Income Statement

2022-12-31

Consolidated Statements of Operations and Other Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Consolidated Statements of Operations and Other Comprehensive Loss
Revenue	$ 2,406,840	$ 2,032,707	$ 1,093,962
Expenses:
Cost of revenue (exclusive of depreciation and amortization, which is shown separately below)	743,987	650,258	390,829
Operating expenses:
Advertising and marketing	623,536	416,726	226,146
Sales	227,172	250,581	154,052
Technology and development	333,629	311,884	164,941
General and administrative	449,855	438,007	506,684
Acquisition, integration, and transformation costs	15,620	26,643	88,236
Restructuring costs	7,416	0	0
Depreciation and amortization	256,027	204,239	69,495
Goodwill impairment	13,402,812	0	0
Total expenses	16,060,054	2,298,338	1,600,383
Loss from operations	(13,653,214)	(265,631)	(506,421)
Loss on extinguishment of debt	0	43,748	9,077
Other expense (income), net	859	(5,088)	545
Interest expense, net	9,270	80,365	59,950
Loss before provision for income taxes	(13,663,343)	(384,656)	(575,993)
Provision for income taxes	(3,812)	44,137	(90,857)
Net loss	(13,659,531)	(428,793)	(485,136)
Other comprehensive income (loss), net of tax:
Currency translation adjustment and other	(36,491)	(24,803)	35,757
Comprehensive loss	$ (13,696,022)	$ (453,596)	$ (449,379)
Net loss per share, basic (in dollars per share)	$ (84.60)	$ (2.73)	$ (5.36)
Net loss per share, diluted (in dollars per share)	$ (84.60)	$ (2.73)	$ (5.36)
Weighted-average shares used to compute basic net loss per share	161,457,123	156,939,349	90,509,229
Weighted-average shares used to compute diluted net loss per share	161,457,123	156,939,349	90,509,229

TDOC Balance Sheet

2022-12-31

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 918,182	$ 893,480
Short-term investments	0	2,537
Accounts receivable, net of allowance of $14,800 and $12,384, respectively	210,554	168,956
Inventories	56,342	73,079
Prepaid expenses and other current assets	130,310	87,387
Total current assets	1,315,388	1,225,439
Property and equipment, net	29,641	27,234
Goodwill	1,073,190	14,504,174
Intangible assets, net	1,836,765	1,910,278
Operating lease - right-of-use assets	41,831	46,780
Other assets	48,540	20,703
Total assets	4,345,355	17,734,608
Current liabilities:
Accounts payable	47,690	47,257
Accrued expenses and other current liabilities	168,693	102,933
Accrued compensation	81,554	91,941
Deferred revenue-current	90,457	75,569
Advances from financing companies	11,375	13,313
Total current liabilities	399,769	331,013
Other liabilities	1,618	1,492
Operating lease liabilities, net of current portion	38,042	41,773
Deferred revenue, net of current portion	3,872	3,834
Advances from financing companies, net of current portion	8,082	9,291
Deferred taxes, net	50,939	75,777
Convertible senior notes, net	1,535,288	1,225,671
Commitments and contingencies (Note 13)
Stockholders' equity:
Common stock, $0.001 par value; 300,000,000 shares authorized; 162,840,360 shares and 160,469,325 shares issued and outstanding as of December 31, 2022 and December 31, 2021, respectively	163	160
Additional paid-in capital	17,358,645	17,473,336
Accumulated deficit	(15,008,287)	(1,421,454)
Accumulated other comprehensive loss	(42,776)	(6,285)
Total stockholders' equity	2,307,745	16,045,757
Total liabilities and stockholders' equity	$ 4,345,355	$ 17,734,608